STOCK TITAN

Becton, Dickinson and Company - $BDX STOCK NEWS

Welcome to our dedicated page for Becton, Dickinson and Company news (Ticker: $BDX), a resource for investors and traders seeking the latest updates and insights on Becton, Dickinson and Company stock.

Becton, Dickinson and Company (BD) (NYSE: BDX) is a global medical technology firm committed to advancing healthcare through the development, manufacture, and sale of a broad range of medical supplies, devices, laboratory equipment, and diagnostic products. Established in 1897, BD's mission is to enhance medical discovery, diagnostics, and care delivery. The company's extensive product portfolio serves healthcare institutions, physicians, life science researchers, and others across the globe.

BD is noted for being the world’s largest manufacturer and distributor of medical surgical products such as needles, syringes, and sharps-disposal units. The company also excels in producing pre-filled devices, diagnostic instruments, and reagents. Furthermore, BD offers sophisticated flow cytometry and cell-imaging systems. BD Medical represents nearly half of the company's total business, while BD Life Sciences and BD Interventional contribute 27% and 24% of the 2023 revenue, respectively. Impressively, international revenue accounts for 43% of the company's business.

Recent achievements and projects underscore BD's commitment to innovation and sustainability. The company recently collaborated with health care institutions in Denmark to explore recycling used blood collection tubes, achieving significant environmental advancements without compromising safety or quality.

In a pivotal development, BD announced the global commercial release of new cell sorters, enabling researchers in fields such as cell biology, cancer research, and immunology to gain new insights. The BD FACSDiscover™ S8 Cell Sorters incorporate groundbreaking technologies like BD CellView™ Image Technology and BD SpectralFX™ Technology, significantly enhancing real-time imaging and spectral flow cytometry.

BD also reported robust financial performance for the second quarter of fiscal 2024, highlighting strong operating margins and cash flow. This success led to an optimistic outlook and an increased earnings guidance, demonstrating the company’s resilience and strategic execution.

Further solidifying its market position, BD is set to acquire Edwards Lifesciences' Critical Care product group for $4.2 billion. This acquisition expands BD’s portfolio in smart connected care solutions, leveraging advanced AI algorithms for better patient outcomes and adding significant value to its operations.

With a presence in almost every country and a workforce of over 70,000 employees, BD remains dedicated to advancing the world of health. The company works closely with customers and partners globally to address complex health challenges, enhance clinical outcomes, and expand access to healthcare.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.05%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.17%
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.24%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none

FAQ

What does Becton, Dickinson and Company (BD) specialize in?

BD specializes in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products.

What are BD's main business segments?

BD’s main business segments include BD Medical, BD Life Sciences, and BD Interventional.

What recent projects has BD undertaken?

BD has collaborated on recycling used blood collection tubes in Denmark and launched new cell sorters for enhanced research in cell biology, cancer, and immunology.

How much of BD's revenue comes from international markets?

International revenue accounts for 43% of BD's total business.

What significant acquisition has BD announced recently?

BD announced the acquisition of Edwards Lifesciences' Critical Care product group for $4.2 billion.

How many employees does BD have?

BD has over 70,000 employees globally.

Where can I find more information about BD's financial performance?

Information about BD's financial performance can be found on their investor relations website at www.bd.com/investors.

What is the significance of the BD FACSDiscover™ S8 Cell Sorters?

The BD FACSDiscover™ S8 Cell Sorters enable real-time imaging and spectral flow cytometry, allowing researchers to gain new insights in various scientific fields.

Which regulatory body recently issued a safety communication regarding syringes?

The U.S. Food and Drug Administration (FDA) issued the safety communication.

What is BD's approach to sustainability?

BD is committed to sustainable innovation, including collaborations to recycle medical plastics and initiatives to minimize its environmental footprint.

Becton, Dickinson and Company

NYSE:BDX

BDX Rankings

BDX Stock Data

67.55B
288.20M
0.31%
89.29%
1.01%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FRANKLIN LAKES